Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study.

Gupta A, Ungaro RC, Steinlauf A, Colombel JF, Feldman S, Leviton A, Onyuka A, Mar P, Cohen M, Freeman R, Nadkarni GN, Klang E

Open source

DOI
10.1093/ibd/izag021
Published
2026 Aug 1
Container
Inflammatory bowel diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ibd/izag021,
  title = {Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study.},
  author = {Gupta A and Ungaro RC and Steinlauf A and Colombel JF and Feldman S and Leviton A and Onyuka A and Mar P and Cohen M and Freeman R and Nadkarni GN and Klang E},
  year = {2026},
  journal = {Inflammatory bowel diseases},
  doi = {10.1093/ibd/izag021},
  url = {https://doi.org/10.1093/ibd/izag021}
}

RIS

TY  - JOUR
TI  - Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study.
AU  - Gupta A
AU  - Ungaro RC
AU  - Steinlauf A
AU  - Colombel JF
AU  - Feldman S
AU  - Leviton A
AU  - Onyuka A
AU  - Mar P
AU  - Cohen M
AU  - Freeman R
AU  - Nadkarni GN
AU  - Klang E
PY  - 2026
JO  - Inflammatory bowel diseases
DO  - 10.1093/ibd/izag021
UR  - https://doi.org/10.1093/ibd/izag021
ER  - 

APA

A, G., RC, U., A, S., JF, C., S, F., A, L., A, O., P, M., M, C., R, F., GN, N., & E, K. (2026). Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study.. Inflammatory bowel diseases. https://doi.org/10.1093/ibd/izag021

Source records